Safety and cost effectiveness of a 10 x 109/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 109/L trigger: A prospective comparative trial in 105 patients with acute myeloid leukemia

Blood

Volumn 91, Issue 10, 1998, Pages 3601-3606

  Wandt, Hannes ^a   Frank, Markus ^b   Ehninger, Gerhard ^b   Schneider, Christiane ^b   Brack, Norbert ^b   Daoud, Ali ^b   Fackler Schwalbe, Irene ^b   Fischer, Jürgen ^b   Gäckle, Ringfried ^b   Geer, Thomas ^b   Harms, Peter ^b   Löffler, Birgit ^b   Öhl, Siegfried ^b   Otremba, Burkhard ^b   Raab, Monika ^b   Schönrock Nabulsi, Petra ^b   Strobel, Gerhard ^b   Winter, Rolf ^b   Link, Hartmut ^b  

^a 5th Medical Department   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLEEDING; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SAFETY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0032525187     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3601.3601_3601_3606     Document Type: Article

References (24)

1. Surgenor DM, Wallace EL, Hao SHS, Chapman RH: Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 322:16, 1990
2. Davey M: Trends in platelet utilization in Canada, 1981-1987. Curr Stud Hematol Blood Transfus 54:89, 1988
3. Pisciotto PT, Benson K, Hume H, Glassman AB, Oberman H, Popovsky M, Hines D, Anderson K: Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 35:498, 1995
4. Wallace EL, Churchill WH, Surgenor DM: Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 35:802, 1995
5. Schiffer CA: Prophylactic platelet transfusion. Transfusion 32: 295, 1992
6. Baer MR, Bloomfield CD: Controversies in transfusion medicine. Prophylactic platelet transfusion therapy. Pro Transfus 32:381, 1992
7. Solomon J, Bofenkamp T, Fahey JL, Chillar RK, Beutler E: Platelet prophylaxis in acute non-lymphoblastic leukemia. Lancet 1:267, 1978
8. Murphy S, Litwin S, Herring LM, Koch P, Remischovsky J, Donaldson MH, Evans AE, Gardner FH: Indications for platelet transfusion in children with acute leukemia. Am J Hematol 12:347, 1982
9. Platelet transfusion therapy. Consensus conference. JAMA 257: 1777, 1987
10. Beutler E: Platelet transfusions: The 20,000 μL trigger. Blood 81:1411, 1993
11. Slichter SJ, Corash L, Schiffer CA, Kickler T: Transfusion medicine - Newer approaches to platelet transfusion therapy, in McArthur JR (ed): Hematology Education Program. Orlando, FL, American Society of Hematology, 1996, p 119
12. Patten E: Controversies in transfusion medicine. Prophylactic platelet transfusion revisited after 25 years. Con Transfus 32:381, 1992
13. Gaydos LA, Freireich EJ, Mantel N: The quantitive relation between platelet count and haemorrhage in patients with acute leukemia. N Engl J Med 266:905, 1962
14. Gmür J, Burger J, Schanz U, Fehr J, Schaffner A: Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet 338:1223, 1991
15. Estey EH, Keating MJ, McCredie KB, Bodey GP, Freireich EJ: Causes of initial remission induction failure in acute myelogenous leukemia. Blood 60:309, 1982
16. Heckman KD, Weiner GJ, Davis CS, Strauss RG, Jones MP, Burns CP: Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10.000/μL versus 20.000/μL. J Clin Oncol 15:1143, 1997
17. Aderica D, Praff G, Santo M, Weinberger A, Pinkhas J: Bleeding due to thrombocytopenia in acute leukemias and re-evaluation of the prophylactic platelet transfusion policy. Am J Med Sci 291:147, 1986
18. 9/L platelets. Blood 88:443a, 1996 (abstr, suppl 1)
19. Slichter SJ, Harker LA: Thrombocytopenia: Mechanisms and management of defects in platelet production. Clin Hematol 7:523, 1978
20. Garfinkel L: Cancer statistics and trends, in Murphy GP, Lawrence W Jr, Lenhard RE Jr (eds): American Cancer Society Textbook of Clinical Oncology. Atlanta, GA, American Cancer Society, 1995, p 1
21. Carson JL, Russell LB, Taragin MI, Sonnenberg FA, Duff AE, Bauer S: The risks of blood transfusion: The relative influence of acquired immunodeficiency syndrome and non-A, non-B hepatitis. Am J Med 92:45, 1992
22. Blajchman MA, Ali AM: Bacteria in the blood supply: An overlooked issue in transfusion medicine, in Nance SJ (ed): Blood Safety: Current Challenges. Bethesda, MD, American Association of Blood Banks, 1992, p 213
23. Birkmeyer JD, Aubuchon JP, Littenberg B: Estimates of risk of posttransfusion hepatitis. Am J Med 93:356, 1992
24. Higby DJ, Cohen E, Holland JF, Sinks L: The prophylactic treatment of thrombocytopenic leukemic patients with platelets: A double blind study. Transfusion 14:440, 1974